MultiHance^® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Omniscan™ (gadodiamide)¹

The ENHANCE Study
Rowley et al.
55-year-old woman with glioblastoma with recurrent disease

These are representative images from reference studies; individual results may vary.
Reference: 1. Rowley HA, Scialfa G, Gao PY, et al. Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide. AJNR Am J Neuroradiol. 2008;29(9):1684-1691.